Events

Multidisciplinary Day of Hepatology and Hepatic Transplantation

15 September, 2022
Lyon, France

ENYO Pharma sponsored and attent the Multidisciplinary Day of Hepatology and Hepatic Transplantation organized by Pr. Fabien Zoulim, Head of the Hepatology Department of the Hospices Civils de Lyon (HCL) the last September 15 at the Institute of Cognitive Sciences in Lyon, France. This annual seminar gathered around 150 professionals in hepatology.

Read more »

EASL – International Liver Congress 2022

22-26 June, 2022
London, UK.

ENYO Pharma will attend the EASL International Liver Congress at London in April 2022.

https://easl.eu/event/international-liver-congress-2022/

Read more »

HBV Forum 8 – Hepatitis B

21 June, 2022
London, UK

ENYO Pharma was attending HBV Forum 8 in London. The HBV Forum aims to advance the regulatory science for novel HBV therapeutic interventions and its associated morbidities in real time by providing an independent and neutral environment for ongoing multi-stakeholder dialogue.

https://forumresearch.org/hbv-forum/hbv-foruman-overview/

Read more »

EIC Growth Club – Tech Tour Health 2022

20-22 June, 2022
Lausanne, Switzerland

ENYO Pharma was participating as a member of the EIC Growth Club in Tech Tour Health 2022 to secure growth, exchange international contacts and build long-lasting relations with some of the most active investors and other innovators in Healthcare space.

https://techtour.com/events/2022/6/event-tech-tour-health-2022%5B2%5D.html

Read more »

AASLD-EASL HBV Endpoints 2022

3-4 June, 2022
Washington, US

ENYO Pharma was attending AASLD-EASL HBV Endpoints 2022 to share news on therapeutic endpoints, trial designs and safety concerns with regards to novel therapeutic approaches for treatment of chronic hepatitis B and D. It was a great opportunity to meet academic, regulatory, pharmaceutical communities and patients in liver disease area.

https://easl.eu/event/aasld-easl-endpoints-2022/

Read more »